Carey Stephen P.'s Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Mar 5, 2026
- Accession no.
- 0001674236-26-000008
- Filed
- Mar 5, 2026
- Trade date
- Mar 5, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $552.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carey Stephen P.CIK 0001674236 | Officer (SVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Common Stock | MOption exerciseAcquired | +3,312 | $49.51 | +$163,977.12 | 192,855 | Direct | |
| Mar 5, 2026 | Common Stock | SSaleDisposed | −3,312 | $75.42 | −$249,791.04 | 189,543 | Direct | |
| Mar 5, 2026 | Common Stock | SSaleDisposed | −4,000 | $75.56 | −$302,240 | 185,543 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Common Stock | MOption exerciseDisposed | −3,312 | $49.51 | −$163,977.12 | 9,938 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.